Oral |
Mice |
10 mg/kg (n=10) 20 mg/kg (n=10) 40 mg/kg (n=10) 80 mg/kg (n=10) |
28 |
The doses of 40 and 80 mg/kg MSG determined:
Neuronal damage in the cerebrum, hippocampus and cerebellum;
Increase in plasma glutamate and glutamine, but not in brain tissue;
Superoxide dismutase and catalase decrease and nitric oxide increased in brain tissue.
|
(Onaolapo et al., 2016)
|
Subcutaneous |
Newborn Wistar rats |
4 g/kg (n=8) |
4 (postnatal days 1, 3, 5, and 7) |
Induces neuronal death;
Alters the expression of hippocampal NMDA receptor subunit NR1, of the AMPA receptor subunits GluR1/GluR2;
Increases the expression of the NRSF gene silencing factor via p38-MAPK pathway.
|
(Rivera-Cervantes et al., 2014) |
Subcutaneous |
Male Wistar rats |
5 mg/kg (n=8) |
30 |
Elevation in lipid peroxidation markers;
Increase of glutathione-s-transferase, superoxide dismutase and catalase activities and gene expression;
Decrease in glutathione content;
Increased levels of brain and serum cholinesterase, creatin phosphokinase and lactate dehydrogenase;
Upregulation of pro-apoptotic Bax in neuronal cells.
|
(Sadek et al., 2016) |
Subcutaneous |
CFW strain mice |
2 g/kg on the 2nd and 4th postnatal days 4 g/kg, on the 6th, 8th and 10th postnatal days (n=8) |
5 |
MSG postnatal treatment led to adult mice with:
Increased susceptibility of the depressor effect of aminooxyacetic acid;
Other effects: obesity (not due to hyperphagia) body and tail length shortening, cryptorchidism.
|
(Campos-Sepulveda et al., 2009) |
Intraperitoneal |
Adult female Wistar rats |
2 g/kg |
7 |
Significant decrease in spontaneous locomotor activity;
Impairment of oxidative defense in brain tissue (raised levels of lipid peroxides, nitrite concentration, reduced activities of glutathione-s-transferase and catalase, depletion of glutathione);
Alteration of hippocampal neuronal histology;
|
(Shivasharan, Nagakannan, Thippeswamy, & Veerapur, 2014) |
Intraperitoneal |
Wistar albino rats of both sexes |
2 g/kg |
7 |
Behavioral and physiological alterations (precipitation of aggressiveness, decreased locomotor activity and loss of muscle strength);
Loss in the hippocampal region, marked cerebral edema, neuronal eosinophilia;
Decreased glutathione and reduced the superoxide dismutase and catalase activities in brain tissue.
|
(Swamy et al., 2014) |